van Tol MJ - Search Results

1

Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro.

Calkoen FG, Vervat C, van Pel M, de Haas V, Vijfhuizen LS, Eising E, Kroes WG, 't Hoen PA, van den Heuvel-Eibrink MM, Egeler RM, van Tol MJ, Ball LM. Calkoen FG, et al. Among authors: van den heuvel eibrink mm, van pel m, van tol mj. Stem Cell Res. 2015 Mar;14(2):198-210. doi: 10.1016/j.scr.2015.01.006. Epub 2015 Jan 28. Stem Cell Res. 2015. PMID: 25679997 Free article.

2

Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL.

Annels NE, Willemze AJ, van der Velden VH, Faaij CM, van Wering E, Sie-Go DM, Egeler RM, van Tol MJ, Révész T. Annels NE, et al. Among authors: van der velden vh, van tol mj, van wering e. Blood. 2004 Apr 1;103(7):2806-8. doi: 10.1182/blood-2003-06-1812. Epub 2003 Dec 4. Blood. 2004. PMID: 14656893 Free article.

3

Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.

Ball LM, Lankester AC, Bredius RG, Fibbe WE, van Tol MJ, Egeler RM. Ball LM, et al. Among authors: van tol mj. Bone Marrow Transplant. 2005 Mar;35 Suppl 1:S35-8. doi: 10.1038/sj.bmt.1704842. Bone Marrow Transplant. 2005. PMID: 15812528

4

Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity.

van Tol MJ, Claas EC, Heemskerk B, Veltrop-Duits LA, de Brouwer CS, van Vreeswijk T, Sombroek CC, Kroes AC, Beersma MF, de Klerk EP, Egeler RM, Lankester AC, Schilham MW. van Tol MJ, et al. Among authors: van vreeswijk t. Bone Marrow Transplant. 2005 Mar;35 Suppl 1:S73-6. doi: 10.1038/sj.bmt.1704852. Bone Marrow Transplant. 2005. PMID: 15812536 Review.

5

Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.

Lankester AC, Visser LF, Hartwig NG, Bredius RG, Gaspar HB, van der Burg M, van Tol MJ, Gross TG, Egeler RM. Lankester AC, et al. Among authors: van tol mj, van der burg m. Bone Marrow Transplant. 2005 Jul;36(2):99-105. doi: 10.1038/sj.bmt.1705016. Bone Marrow Transplant. 2005. PMID: 15908972

6

A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.

Faaij CM, Lankester AC, Spierings E, Hoogeboom M, Bowman EP, Bierings M, Révész T, Egeler RM, van Tol MJ, Annels NE. Faaij CM, et al. Among authors: van tol mj. Br J Haematol. 2006 Jun;133(5):538-49. doi: 10.1111/j.1365-2141.2006.06058.x. Br J Haematol. 2006. PMID: 16681643 Free article.

7

Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.

Annels NE, Kalpoe JS, Bredius RG, Claas EC, Kroes AC, Hislop AD, van Baarle D, Egeler RM, van Tol MJ, Lankester AC. Annels NE, et al. Among authors: van tol mj, van baarle d. Clin Infect Dis. 2006 Jun 15;42(12):1743-8. doi: 10.1086/503838. Epub 2006 May 4. Clin Infect Dis. 2006. PMID: 16705581

8

ABO incompatible stem cell transplantation in children does not influence outcome.

Helming AM, Brand A, Wolterbeek R, van Tol MJ, Egeler RM, Ball LM. Helming AM, et al. Among authors: van tol mj. Pediatr Blood Cancer. 2007 Sep;49(3):313-7. doi: 10.1002/pbc.21025. Pediatr Blood Cancer. 2007. PMID: 16960869

9

Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.

de Hooge AS, Berghuis D, Santos SJ, Mooiman E, Romeo S, Kummer JA, Egeler RM, van Tol MJ, Melief CJ, Hogendoorn PC, Lankester AC. de Hooge AS, et al. Among authors: van tol mj. Clin Cancer Res. 2007 Jan 1;13(1):206-14. doi: 10.1158/1078-0432.CCR-06-1457. Clin Cancer Res. 2007. PMID: 17200356

10

NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.

Verhoeven DH, de Hooge AS, Mooiman EC, Santos SJ, ten Dam MM, Gelderblom H, Melief CJ, Hogendoorn PC, Egeler RM, van Tol MJ, Schilham MW, Lankester AC. Verhoeven DH, et al. Among authors: van tol mj. Mol Immunol. 2008 Sep;45(15):3917-25. doi: 10.1016/j.molimm.2008.06.016. Epub 2008 Jul 26. Mol Immunol. 2008. PMID: 18657862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page